Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

3 T MRI in the Preoperative TN Staging and Prediction of Response to Neoadjuvant Therapy in Patients With Esophageal Cancer

NCT03635619 is registered in ClinicalTrials.gov with Henan Cancer Hospital as lead sponsor.

NCT NCT03635619
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03635619 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
3 T MRI in the Preoperative TN Staging and Prediction of Response to Neoadjuvant Therapy in Patients With Esophageal Cancer
Lead sponsor
Henan Cancer Hospital
Phase
Observational
Overall status
Unknown status
Start date
September 2, 2018
Completion date
December 30, 2023
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal cancer tnm staging, magnetic resonance imaging, prognosis